Skip to main content

Table 2 Prescription patterns of comorbidity-relevant medication at baseline

From: Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases – a claims data analysis

Individuals with prescriptions of therapeutic agents for comorbid conditions
  N %
Treatment of heart insufficiency/cardiac arrhythmia 11,267 30.6
 Digitalis glycosides (ATC code C01AA) 1516 4.1
 Anti-arrhythmic drugs (ATC code C01BD) 541 1.5
 Diuretic drugs (ATC code C03) 10,631 28.8
Treatment of cardiovascular disease 19,376 52.6
 Statins (ATC code C10AA) 5881 16.0
 Beta-blockers (ATC code C07) 11,038 30.0
 ACE inhibitors (ATC codes C09AA C09B) 9309 25.3
 Antiotensin-I-antagonists (ATC codes C09CA C09D) 4664 12.7
Treatment with anti-clotting medication 7692 20.9
 Antiplatelet drugs (ATC code B01AC) 4071 11.1
 Vitamin-K antagonists (ATC code B01AB) 2428 6.60
 Heparin (−derivates) (ATC code B01AA) 2285 6.2
Treatment with anti-acid drugs 14,596 39.6
 Proton-pump inhibitors (PPI) (ATC code A02BC) 14,171 38.5
 Histamine-H2 blockers (ATC code A02BA) 463 1.3
Treatment with anti-depressants (ATC code N06A) 3952 10.7
Treatment with anti-diabetic drugs (ATC codes A10A, A10B) 5891 16.0
Treatment with drugs against obstructive airway disease 11,021 29.9
 Long-acting beta2 agonists (LABA) (ATC code R03AC) 2640 7.2
 Long-acting muscarinic antagonists (LAMA) (ATC code R03BB) 4690 12.7
 Inhaled corticosteroids (ICS) (ATC code R03BA) 2794 7.6
 Combination product LABA/ICS (ATC code R03AK) 5135 13.9
 Combination product LABA/LAMA (ATC code R03AL) 40 0.1
Treatment with specific PH drugs (ATC codes G04BE03, B01AC09, C03KX) 265 0.7